Peaked at #3 Now #3
OpenAI acquires Orchestra Bio
OpenAI acquired Orchestra Bio to combine with its Rosalind life-sciences models and streamline drug development.
Key points
- OpenAI acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
- OpenAI will build on Rosalind, its AI models and tools for life sciences research, to streamline those operations.
- OpenAI welcomed @ashokaraj_ and team.
Key points and the reaction summary are written by AI from the posts on this page. Check the original post. How we use AI
Original post
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
https://t.co/vi51OhznQn
Top replies on X
Sign in to see 5 top replies from X
From @notjazii, @OjWentworth, @iammaxdemian and others. Spam removed, with English and Chinese translations.
Discussion 0
Sign up Sign in to join the discussion
No comments yet. Start the conversation.